LamNNLentineKLGargAX. End-stage renal disease risk in live kidney donors: what have we learned from two recent studies?Curr Opin Nephrol Hypertension. 2014;23(6):592–596.
5.
KasiskeBL. Outcomes after living kidney donation: what we still need to know and why. Am J Kidney Dis. 2014;64(3):335–337.
6.
GillJSTonelliM. Understanding rare adverse outcomes following living kidney donation. JAMA. 2014;311(6):577–579.
7.
MatasAJWadstromJIbrahimHN. Kidney donation and risk of ESRD. JAMA. 2014;312(1):92–93.
8.
CsikezNRicciardiRTsengJFShahSH. Current status of surgcial management of acute cholecystitis in the United States. World J Surg. 2008;32(10):2230–2236.
9.
MalenkaDJBaronJAJohansenSWahrenbergerJWRossJM. The framing effect of relative and absolute risk. J Gen Internal Med. 1993;8(10):543–548.
10.
LaPointe RudowDHaysRBaligaP. Consensus conference on best practices in live kidney donation: recommendations to optimize education, access, and care. Am J Transplant. 2015;15(4):914–922.
11.
GordonEJMulleeJBeauvaisN. Education and informed consent about increased risk donor kidneys: a national survey of non-physician transplant providers. Transplant Infect Dis. 2014; 16(2):251–260.
